for the Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses”.

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses

JCI Insight(2022)10.1172/jci.insight.163471

N/A

0.587DataRank · unranked

13 citations

Alba Grifoni, Daniela Weiskopf, Urvi M. Parikh, Amy Heaps, Farhoud Faraji +15 more

SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae371

N/A

0DataRank · unranked

13 citations

Sydney I. Ramirez, Hallie Cohn, Urvi M. Parikh, Amy Heaps, Scott F. Sieg +22 more